259 related articles for article (PubMed ID: 19076216)
1. Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events.
Apolloni S; Montilli C; Finocchi P; Amadio S
FEBS J; 2009 Jan; 276(2):354-64. PubMed ID: 19076216
[TBL] [Abstract][Full Text] [Related]
2. Purinergic signalling and disorders of the central nervous system.
Burnstock G
Nat Rev Drug Discov; 2008 Jul; 7(7):575-90. PubMed ID: 18591979
[TBL] [Abstract][Full Text] [Related]
3. Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis.
Amadio S; Apolloni S; D'Ambrosi N; Volonté C
J Neurochem; 2011 Mar; 116(5):796-805. PubMed ID: 21214557
[TBL] [Abstract][Full Text] [Related]
4. Involvement of P2 receptors in the growth and survival of neurons in the CNS.
Franke H; Illes P
Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837
[TBL] [Abstract][Full Text] [Related]
5. Membrane compartments and purinergic signalling: occurrence and function of P2X receptors in lung.
Barth K; Kasper M
FEBS J; 2009 Jan; 276(2):341-53. PubMed ID: 19076210
[TBL] [Abstract][Full Text] [Related]
6. Purinergic signalling: from normal behaviour to pathological brain function.
Burnstock G; Krügel U; Abbracchio MP; Illes P
Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261
[TBL] [Abstract][Full Text] [Related]
7. P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses.
Köles L; Furst S; Illes P
Drug News Perspect; 2005 Mar; 18(2):85-101. PubMed ID: 15883618
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiological roles of P2 receptors in glial cells.
Abbracchio MP; Verderio C
Novartis Found Symp; 2006; 276():91-103; discussion 103-12, 275-81. PubMed ID: 16805425
[TBL] [Abstract][Full Text] [Related]
9. Purinergic signalling--an overview.
Burnstock G
Novartis Found Symp; 2006; 276():26-48; discussion 48-57, 275-81. PubMed ID: 16805422
[TBL] [Abstract][Full Text] [Related]
10. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future.
Burnstock G
Bioessays; 2012 Mar; 34(3):218-25. PubMed ID: 22237698
[TBL] [Abstract][Full Text] [Related]
11. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Burnstock G
Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
13. ATP and the pathogenesis of COPD.
Mortaz E; Folkerts G; Nijkamp FP; Henricks PA
Eur J Pharmacol; 2010 Jul; 638(1-3):1-4. PubMed ID: 20423711
[TBL] [Abstract][Full Text] [Related]
14. P2 receptor signalling, proliferation of astrocytes, and expression of molecules involved in cell-cell interactions.
Neary JT; Kang Y; Shi YF; Tran MD; Wanner IB
Novartis Found Symp; 2006; 276():131-43; discussion 143-7, 233-7, 275-81. PubMed ID: 16805427
[TBL] [Abstract][Full Text] [Related]
15. Purinergic contribution to amyotrophic lateral sclerosis.
Volonté C; Apolloni S; Parisi C; Amadio S
Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
[TBL] [Abstract][Full Text] [Related]
16. P2X receptors and synaptic plasticity.
Pankratov Y; Lalo U; Krishtal OA; Verkhratsky A
Neuroscience; 2009 Jan; 158(1):137-48. PubMed ID: 18495357
[TBL] [Abstract][Full Text] [Related]
17. Molecular physiology of P2X receptors and ATP signalling at synapses.
Khakh BS
Nat Rev Neurosci; 2001 Mar; 2(3):165-74. PubMed ID: 11256077
[TBL] [Abstract][Full Text] [Related]
18. Lack of P2X receptor mediated currents in astrocytes and GluR type glial cells of the hippocampal CA1 region.
Jabs R; Matthias K; Grote A; Grauer M; Seifert G; Steinhäuser C
Glia; 2007 Dec; 55(16):1648-55. PubMed ID: 17849469
[TBL] [Abstract][Full Text] [Related]
19. ALS: focus on purinergic signalling.
Volonté C; Apolloni S; Carrì MT; D'Ambrosi N
Pharmacol Ther; 2011 Oct; 132(1):111-22. PubMed ID: 21704075
[TBL] [Abstract][Full Text] [Related]
20. Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters.
Volonté C; D'Ambrosi N
FEBS J; 2009 Jan; 276(2):318-29. PubMed ID: 19076212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
